Full text
5,442 characters
· extracted from
preprint-html
· click to expand
An Update on Patent issues regarding Antibody Drug Conjugates | Authorea try { document.documentElement.classList.add('js'); } catch (e) { } var _gaq = _gaq || []; _gaq.push(['_setAccount', 'G-8VDV14Y67G']); _gaq.push(['_trackPageview']); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); Skip to main content Preprints Collections Wiley Open Research IET Open Research Ecological Society of Japan All Collections About About Authorea FAQs Contact Us Quick Search anywhere Search for preprint articles, keywords, etc. Search Search ADVANCED SEARCH SCROLL This is a preprint and has not been peer reviewed. Data may be preliminary. 23 April 2025 V1 Latest version Share on An Update on Patent issues regarding Antibody Drug Conjugates Author : Ulrich Storz 0000-0002-9565-9857 [email protected] Authors Info & Affiliations https://doi.org/10.22541/au.174542773.39574180/v1 Published Nature Biotechnology Version of record Peer review timeline 429 views 194 downloads Contents Abstract Supplementary Material Information & Authors Metrics & Citations View Options References Figures Tables Media Share Abstract In 2015, the author of this article has published a first review on the patent landscape of antibody drug conjugate s (ADCs).[1](#ref-0001) Now, 10 years later, it is time for a wrap-up. While the basic principles discussed in that earlier article still apply, the ADC landscape has dramatically evolved and diversified in the meantime. Supplementary Material File (adc_patents_2025_st_draft_1.docx) Download 507.70 KB File (adc_patents_2025_st_tables.docx) Download 64.85 KB Information & Authors Information Version history V1 Version 1 23 April 2025 Peer review timeline Published Nature Biotechnology Version of Record 18 May 2026 Published Copyright This work is licensed under a Non Exclusive No Reuse License. Keywords adc antibodies biochemical engineering medical biotechnology patent Authors Affiliations Ulrich Storz 0000-0002-9565-9857 [email protected] Michalski Huttermann & Partner Patentanwalte MBB View all articles by this author Metrics & Citations Metrics Article Usage 429 views 194 downloads .FvxKWukQNSOunydq8rnd { width: 100px; } Citations Download citation Ulrich Storz. An Update on Patent issues regarding Antibody Drug Conjugates. Authorea . 23 April 2025. DOI: https://doi.org/10.22541/au.174542773.39574180/v1 If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download. For more information or tips please see 'Downloading to a citation manager' in the Help menu . Format Please select one from the list RIS (ProCite, Reference Manager) EndNote BibTex Medlars RefWorks Direct import Tips for downloading citations document.getElementById('citMgrHelpLink').addEventListener('click', function() { popupHelp(this.href); return false; }); $(".js__slcInclude").on("change", function(e){ if ($(this).val() == 'refworks') $('#direct').prop("checked", false); $('#direct').prop("disabled", ($(this).val() == 'refworks')); }); View Options View options PDF View PDF Figures Tables Media Share Share Share article link Copy Link Copied! Copying failed. Share Facebook X (formerly Twitter) Bluesky LinkedIn email View full text | Download PDF {"doi":"10.22541/au.174542773.39574180/v1","type":"Article"} Now Reading: Share Figures Tables Close figure viewer Back to article Figure title goes here Change zoom level Go to figure location within the article Download figure Toggle share panel Toggle share panel Share Toggle information panel Toggle information panel Go to previous graphic Go to next graphic Go to previous table Go to next table All figures All tables View all material View all material xrefBack.goTo xrefBack.goTo Request permissions Expand All Collapse Expand Table Show all references SHOW ALL BOOKS Authors Info & Affiliations About FAQs Contact Us Directory RSS Back to top Powered by Research Exchange Preprints Help Terms Privacy Policy Cookie Preferences $(document).ready(() => setTimeout(() => { let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" ")); $.get("/resource/lodash?t="+_bnt); },4000)); (function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'9ffb4700add2df94',t:'MTc3OTQ0NzIwOQ=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.